Previous 10 | Next 10 |
Editor's note: This is a transcript version of our recent podcast on Cannabics Pharmaceuticals (CNBX). Listen to or subscribe to The Cannabis Investing Podcast on Libsyn , SoundCloud or Apple Podcasts/iTunes . Introduction Rena Sherbill: Jonathan Liss and...
By Rena Sherbill Jonathan Liss and I covered the CannaTech conference in Tel Aviv that ran from April 1-2. We talked with a wide variety of attendees and presenters - from executives and scientists to venture capitalists, money managers, marketers and journalists. We'll be rel...
Cannabics Pharmaceuticals (OTCQB: CNBX ) is taking a unique approach in treating different types of cancers with its drug-screening tools and artificial intelligence (AI) platform to develop cannabinoid-based therapies that are more specific to a patient. Although the company is a publicly...
NEW YORK , March 13, 2019 /PRNewswire/ -- OTC Markets Group Inc . (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market company presentations at the 31 st Annual ROTH Con...
TEL AVIV, Israel and BETHESDA, Maryland , March 12, 2019 Cannabics Pharmaceuticals Inc . (OTCQB:CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced that Mr. Daniel Birnbaum , CEO of SodaStream, the world's leader in at-home spar...
HOD HASHARON, Israel , March 6 , 2019 /PRNewswire/ -- Wize Pharma, Inc. ("Wize Pharma" or the "Company") (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced that the Company closed a deal with C...
BETHESDA, Maryland and TEL AVIV, Israel, March 6, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) a world leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced that it has closed an agreement with Wize...
TEL AVIV, Israel and BETHESDA, Maryland , Feb. 19, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc . (OTCQB:CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced that it has submitted a proto...
Cannabics Pharmaceuticals ( OTCQB:CNBX ) and Wize Pharma ( OTCQB:WIZP ) have agreed to form a joint venture (JV) aimed at developing cannabinoid-based treatments for ophthalmic disorders, including dry eye disease. More news on: Cannabics Pharmaceuticals Inc., Wize Pharma, Inc., Hea...
HOD HASHARON, Israel, Feb. 7, 2019 /PRNewswire/ -- Wize Pharma, Inc. ("Wize Pharma" or the "Company") (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced that the Company has signed an agreem...
News, Short Squeeze, Breakout and More Instantly...
Cannabics Pharmaceuticals Inc Company Name:
CNBX Stock Symbol:
OTCMKTS Market:
Cannabics Pharmaceuticals Inc Website:
CNBX Pharmaceuticals Inc (CNBX) is expected to report for Q1 2003
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma PR Newswire REHOVOT, Israel and BETHESDA, MD , Nov. 8, 2022 /PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader i...
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy PR Newswire REHOVOT, Israel and BETHESDA, MD. , Oct. 18, 2022 /PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of...